Considering it together with a clinical study by Hamelin et al. [216] that the higher the TSPO binding signal in the early stage of AD, the better the clinical prognosis, it is possible that the initial increase in TSPO expression through astrocyte activation is important for improving the clinical prognosis of AD. Here, TSPO is linked to Alzheimer disease.